Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

72.09
-5.8100-7.46%
Pre-market: 72.500.4100+0.57%08:46 EDT
Volume:4.36M
Turnover:317.52M
Market Cap:10.02B
PE:-10.04
High:74.42
Open:73.88
Low:71.66
Close:77.90
52wk High:88.31
52wk Low:44.91
Shares:139.02M
Float Shares:138.02M
Volume Ratio:3.44
T/O Rate:3.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1827
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-28.09%
PB:-57.77
PE(LYR):-11.02

Loading ...

Cytokinetics to Host Annual Symposium on Contemporary Landscapes in Muscle Biology (CLIMB)

GlobeNewswire
·
May 14

Cytokinetics management participates in RBC Capital Markets Global Healthcare Conference fireside chat

Reuters
·
May 13

Cytokinetics Is Maintained at Overweight by JP Morgan

Dow Jones
·
May 12

U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis

Reuters
·
May 12

Cytokinetics says aficamten beats metoprolol in Phase 3 MAPLE-HCM analysis

Reuters
·
May 11

Cytokinetics Announces New Data Related to Myqorzo® (Aficamten) at Esc Heart Failure 2026

THOMSON REUTERS
·
May 11

Cytokinetics Announces New Data Related to MYQORZO® (aficamten) at ESC Heart Failure 2026

GlobeNewswire
·
May 11

Cytokinetics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 11

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
May 11

Cytokinetics Raises $760 Million in Stock Offering

TIPRANKS
·
May 09

Edgewise Therapeutics' Update for EDG-7500 Could Boost Shares, RBC Says

MT Newswires Live
·
May 09

Stock Track | Cytokinetics Soars 5.64% Intraday on Successful $805 Million Public Offering and Positive Clinical Trial Data

Stock Track
·
May 09

Cytokinetics prices 11,338,028-share follow-on offering at $71, raising $805 million

Reuters
·
May 08

Press Release: Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $805 Million

Dow Jones
·
May 08

BUZZ-U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise

Reuters
·
May 08

Cytokinetics Inc : Jefferies Raises Target Price to $105 From $90

THOMSON REUTERS
·
May 07

BUZZ-U.S. STOCKS ON THE MOVE-Catalyst Pharma, DoorDash, Tapestry

Reuters
·
May 07

Cytokinetics (CYTK) Gets a Buy from Wells Fargo

TIPRANKS
·
May 07

Cytokinetics price target raised to $119 from $101 at RBC Capital

TIPRANKS
·
May 07

Cytokinetics price target raised to $103 from $90 at Morgan Stanley

TIPRANKS
·
May 07